112 related articles for article (PubMed ID: 25521706)
1. Using administrative data to estimate time to breast cancer diagnosis and percent of screen-detected breast cancers – a validation study in Alberta, Canada.
Yuan Y; Li M; Yang J; Winget M
Eur J Cancer Care (Engl); 2015 May; 24(3):367-75. PubMed ID: 25521706
[TBL] [Abstract][Full Text] [Related]
2. Factors related to breast cancer detection mode and time to diagnosis in Alberta, Canada: a population-based retrospective cohort study.
Yuan Y; Li M; Yang J; Elliot T; Dabbs K; Dickinson JA; Fisher S; Winget M
BMC Health Serv Res; 2016 Feb; 16():65. PubMed ID: 26892589
[TBL] [Abstract][Full Text] [Related]
3. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
Lynge E
APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
[TBL] [Abstract][Full Text] [Related]
4. [Danish Quality Database for Mammography Screening].
Vejborg I; Mikkelsen EM; Schwartz W; Bak M; Lernevall A; Borg Mogensen N; Garne JP
Ugeskr Laeger; 2012 Oct; 174(42):2533. PubMed ID: 23079436
[No Abstract] [Full Text] [Related]
5. Associations among socioeconomic status, patterns of care and outcomes in breast cancer patients in a universal health care system: Ontario's experience.
Kumachev A; Trudeau ME; Chan KK
Cancer; 2016 Mar; 122(6):893-8. PubMed ID: 26696022
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer detection method, diagnostic interval and use of specialized diagnostic assessment units across Ontario, Canada.
Jiang L; Gilbert J; Langley H; Moineddin R; Groome PA
Health Promot Chronic Dis Prev Can; 2018 Oct; 38(10):358-367. PubMed ID: 30303656
[TBL] [Abstract][Full Text] [Related]
7. Effect of recall rate on earlier screen detection of breast cancers based on the Dutch performance indicators.
Otten JD; Karssemeijer N; Hendriks JH; Groenewoud JH; Fracheboud J; Verbeek AL; de Koning HJ; Holland R
J Natl Cancer Inst; 2005 May; 97(10):748-54. PubMed ID: 15900044
[TBL] [Abstract][Full Text] [Related]
8. Missed and true interval and screen-detected breast cancers in a population based screening program.
Hoff SR; Samset JH; Abrahamsen AL; Vigeland E; Klepp O; Hofvind S
Acad Radiol; 2011 Apr; 18(4):454-60. PubMed ID: 21216632
[TBL] [Abstract][Full Text] [Related]
9. Are prognostic factors more favorable for breast cancer detected by organized screening than by opportunistic screening or clinical diagnosis? A study in Loire-Atlantique (France).
Vanier A; Leux C; Allioux C; Billon-Delacour S; Lombrail P; Molinié F
Cancer Epidemiol; 2013 Oct; 37(5):683-7. PubMed ID: 23880147
[TBL] [Abstract][Full Text] [Related]
10. Effect of specialized diagnostic assessment units on the time to diagnosis in screen-detected breast cancer patients.
Jiang L; Gilbert J; Langley H; Moineddin R; Groome PA
Br J Cancer; 2015 May; 112(11):1744-50. PubMed ID: 25942395
[TBL] [Abstract][Full Text] [Related]
11. Breast Cancer Screening Program in Lithuania: Interval Cancers and Program Sensitivity After 7 Years of Mammography Screening.
Steponaviciene L; Vincerzevskiene I; Briediene R; Urbonas V; Vanseviciute-Petkeviciene R; Smailyte G
Cancer Control; 2019; 26(1):1073274819874122. PubMed ID: 31502471
[TBL] [Abstract][Full Text] [Related]
12. Importance of quality in breast cancer screening practice - a natural experiment in Alberta, Canada.
Yuan Y; Vu K; Shen Y; Dickinson J; Winget M
BMJ Open; 2020 Jan; 10(1):e028766. PubMed ID: 31911508
[TBL] [Abstract][Full Text] [Related]
13. Early evaluation of an organised mammography screening program in Greece 2004-2009.
Simou E; Tsimitselis D; Tsopanlioti M; Anastasakis I; Papatheodorou D; Kourlaba G; Gerasimos P; Maniadakis N
Cancer Epidemiol; 2011 Aug; 35(4):375-80. PubMed ID: 21474412
[TBL] [Abstract][Full Text] [Related]
14. A comparison of clinical-pathological characteristics between symptomatic and interval breast cancer.
Meshkat B; Prichard RS; Al-Hilli Z; Bass GA; Quinn C; O'Doherty A; Rothwell J; Geraghty J; Evoy D; McDermott EW
Breast; 2015 Jun; 24(3):278-82. PubMed ID: 25771080
[TBL] [Abstract][Full Text] [Related]
15. Validation of congenital anomaly coding in Canada's administrative databases compared with a congenital anomaly registry.
Metcalfe A; Sibbald B; Lowry RB; Tough S; Bernier FP
Birth Defects Res A Clin Mol Teratol; 2014 Feb; 100(2):59-66. PubMed ID: 24307632
[TBL] [Abstract][Full Text] [Related]
16. Added cancer yield of breast magnetic resonance imaging screening in women with a prior history of chest radiation therapy.
Freitas V; Scaranelo A; Menezes R; Kulkarni S; Hodgson D; Crystal P
Cancer; 2013 Feb; 119(3):495-503. PubMed ID: 22952042
[TBL] [Abstract][Full Text] [Related]
17. Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years.
Miller AB; Baines CJ; To T; Wall C
CMAJ; 1992 Nov; 147(10):1459-76. PubMed ID: 1423087
[TBL] [Abstract][Full Text] [Related]
18. [Tailored Breast Screening Trial (TBST)].
Paci E; Mantellini P; Giorgi Rossi P; Falini P; Puliti D;
Epidemiol Prev; 2013; 37(4-5):317-27. PubMed ID: 24293498
[TBL] [Abstract][Full Text] [Related]
19. Effects of age, breast density, ethnicity, and estrogen replacement therapy on screening mammographic sensitivity and cancer stage at diagnosis: review of 183,134 screening mammograms in Albuquerque, New Mexico.
Rosenberg RD; Hunt WC; Williamson MR; Gilliland FD; Wiest PW; Kelsey CA; Key CR; Linver MN
Radiology; 1998 Nov; 209(2):511-8. PubMed ID: 9807581
[TBL] [Abstract][Full Text] [Related]
20. Film reading in the East Midlands Breast Screening Programme -- are we missing opportunities for earlier diagnosis?
Jenkins J; Murphy AE; Edmondson-Jones M; Sibbering DM; Turnbull AE
Clin Radiol; 2014 Apr; 69(4):385-90. PubMed ID: 24411823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
